About Latika Biotech
Latika Biotech is a Healthcare company. Production of pharmaceutical products for healthcare sectors including cardiology and critical care. The company has 8 employees. Its Indian entity Latika Biotech Private Limited reported revenue of ₹1.25 Cr. Latika Biotech offers products and services including Onco Care Products and Critical Care Products. Its focus areas include Biotechnology, Pharmaceuticals, Drug Manufacturing and Medical Supplies.
Company details
Latika Biotech Pvt. Ltd. is known for manufacturing quality pharmaceutical products that aim to enhance global health outcomes. A commitment to reliability and innovation is demonstrated through ethical business practices and a diverse product line covering areas like gynecology, pediatrics, and critical care. Divisions such as Onco Care and Critical Care are utilized to develop drugs including Amphotericin B and Meropenem, which assist in treating various medical conditions. The company operates from Kolkata, India, with an international presence, and its efforts are directed towards supporting well-being worldwide.
- Employees 8
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Legal Name Latika Biotech Pvt. Ltd
- Date of Incorporation 23 May, 2014
- Jurisdiction Kolkata, West Bengal, India
- Indian entity revenue₹1.25 Cr
FY 2024 · +26% YoY
- Indian entity net loss-₹82.9 Lakh
FY 2024 · -66% margin
- Indian entity EBITDA-₹79.6 Lakh
FY 2024 · -64% margin
- Employee Count8
Associated legal entities of Latika Biotech
Latika Biotech operates through Latika Biotech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Latika Biotech Private Limited CIN U24100WB2014PTC201866 | Active | 23 May 2014 | Kolkata, West Bengal | ₹1.3 Cr | 8 | 3 | View details |
Products & Services of Latika Biotech
Latika Biotech offers a comprehensive portfolio of products and services, including Onco Care Products and Critical Care Products.
Products like Amphotericin B and Oxaliplatin are manufactured for oncology care to address critical health needs.
Products such as Meropenem and Cefriaxone are provided for critical care to support patient treatment in various medical scenarios.
Board of directors of Latika Biotech Private Limited (Latika Biotech)
Latika Biotech Private Limited is the primary company behind Latika Biotech. The board of Latika Biotech Private Limited currently have 3 directors; the longest-serving is Latika Bajoria, appointed in 2014.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Latika Bajoria DIN 00528226 | Director | 23 May 2014 | 12 yrs 5 mo | Latika Biotech Private Limited |
| Akash Bajoria DIN 03583509 | Director | 23 May 2014 | 12 yrs 5 mo | Latika Biotech Private Limited |
| Sarvesh Bajoria DIN 03583565 | Director | 04 Nov 2014 | 11 yrs 11 mo | Latika Biotech Private Limited |
Financials of Latika Biotech
Figures of Latika Biotech Private Limited, the primary company behind Latika Biotech, for FY 2024. Revenue was ₹1.25 Cr (+26% year on year). Net loss was -₹82.9 Lakh (-66% margin). EBITDA was -₹79.6 Lakh (-64% margin). Revenue has grown at a compounded annual rate of -6% over three years and +4% over five years.
- ₹1.25 CrRevenue · FY 2024 · +26% YoY
- -₹82.9 LakhNet loss · -66% margin
- -₹79.6 LakhEBITDA · -64% margin
- ₹1 LakhPaid-up capital
- 8Employees (provident fund records)
- -6%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Latika Biotech Private Limited are on its company page.
Detailed financial statements for Latika Biotech
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Latika Biotech
Latika Biotech has 8 employees.
The primary company behind Latika Biotech, Latika Biotech Private Limited, reported revenue of ₹1.25 Cr for FY 2024, up 26% year on year.
Latika Biotech Pvt. Ltd. is known for manufacturing quality pharmaceutical products that aim to enhance global health outcomes. A commitment to reliability and innovation is demonstrated through ethical business practices and a diverse product line covering areas like gynecology, pediatrics, and critical care. Divisions such as Onco Care and Critical Care are utilized to develop drugs including Amphotericin B and Meropenem, which assist in treating various medical conditions. The company operates from Kolkata, India, with an international presence, and its efforts are directed towards supporting well-being worldwide.
Latika Biotech offers Onco Care Products and Critical Care Products.
Latika Biotech operates through Latika Biotech Private Limited.
The legal entities of Latika Biotech currently have 3 directors, including Latika Bajoria, Sarvesh Bajoria, Akash Bajoria.